More Imugene Ltd news Imugene LtdASX: IMU Dose Escalation in Phase 1 Clinical Trial of CHECKvacc Mar 24, 2022 at 2:36 AM UTC · Issued by Imugene Ltd As issuedPlain English Imugene Ltd has released a press release. View Attachment
